BPC 157 has already hit the mainstream, but should it hit your bloodstream? BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or BPC 157 in Australia: Benefits, side effects, risks and legality BPC157 Seven Hills Medical Centr BPC 157 for Foot Pain Houston Podiatrist Explains BPC 157 Research Guide Canada Dosing, Mechanism & Sourcing